Buenos días con todos, aquí algo interersante sobre el Herpes Zoster....la vacuna.
Saludos
Dr. Carlos Erazo
A study conducted in a clinical practice setting confirms the effectiveness of herpes zoster vaccine, according to a report in JAMA.
In a retrospective cohort study of health plan members, researchers examined the incidence of herpes zoster among some 75,000 vaccinees aged 60 and older and 225,000 age-matched controls who did not receive the vaccine. After a follow-up averaging about 2 years, the incidence of herpes zoster was twice as high among controls as among vaccinees (13.0 vs. 6.4 per 1000 person-years). The difference remained after adjustment for sex, race, presence of chronic disease, and health care utilization. There was also a significant reduction in risk for ophthalmic herpes zoster.
The authors estimate that one episode of herpes zoster would be prevented for every 71 patients vaccinated. They write that their results "support recommendations to offer herpes zoster vaccine to eligible patients of all ages, including the oldest population."
In a retrospective cohort study of health plan members, researchers examined the incidence of herpes zoster among some 75,000 vaccinees aged 60 and older and 225,000 age-matched controls who did not receive the vaccine. After a follow-up averaging about 2 years, the incidence of herpes zoster was twice as high among controls as among vaccinees (13.0 vs. 6.4 per 1000 person-years). The difference remained after adjustment for sex, race, presence of chronic disease, and health care utilization. There was also a significant reduction in risk for ophthalmic herpes zoster.
The authors estimate that one episode of herpes zoster would be prevented for every 71 patients vaccinated. They write that their results "support recommendations to offer herpes zoster vaccine to eligible patients of all ages, including the oldest population."
JAMA article (Free abstract)
No hay comentarios:
Publicar un comentario